Advertisement

Tick-Borne Diseases

  • Jerome Goddard
Chapter
Part of the Infectious Disease book series (ID)

Abstract

Ticks are arachnids which are second only to mosquitoes as vectors of human disease agents. They are many tick-borne diseases worldwide such as Lyme disease, Rocky Mountain spotted fever, ehrlichiosis, anaplasmosis, babesiosis, relapsing fever, and tick-borne encephalitis. This chapter explores the biology, ecology, and disease relationships of ticks, including discussion of the various tick species, where each one occurs, their seasonal activity, what animal hosts they feed on, and the like. Lastly, each of the major tick-borne diseases is presented and discussed, including their geographic distributions, tick vectors, and comments about their treatment, prevention, and control.

Keywords

Arthropods Disease transmission Public health Vector-borne disease Disease cycles Ticks Tick-borne diseases Lyme disease Rocky Mountain spotted fever Ehrlichiosis Anaplasmosis Babesiosis Tick-borne relapsing fever Tularemia Tick paralysis 

References

  1. 1.
    Raoult D, Olson JG. Emerging rickettsioses. In: Scheld WM, Craig WA, Hughes JM, editors. Emerging infections, vol. 3. Washington, DC: ASM Press; 1999. p. 17–35.Google Scholar
  2. 2.
    Goddard J, Norment BR. Spotted fever group rickettsiae in the lone star tick. J Med Entomol. 1986;23:465–72.PubMedCrossRefGoogle Scholar
  3. 3.
    Mixon TR, Campbell SR, Gill JS, Ginsberg HS, Reichard MV, Schulze TL, et al. Prevalence of Ehrlichia, Borrelia, and Rickettsial agents in Amblyomma americanum collected from nine states. J Med Entomol. 2006;43:1261–8.Google Scholar
  4. 4.
    Schriefer ME, Azad AF. Changing ecology of Rocky Mountain spotted fever. In: Sonenshine DE, Mather TN, editors. Ecological dynamics of tickborne zoonoses. New York: Oxford University Press; 1994. p. 314–24.Google Scholar
  5. 5.
    Harden VA. Rocky Mountain spotted fever: history of a twentieth-century disease. Baltimore: Johns Hopkins Press; 1990.Google Scholar
  6. 6.
    Ricketts H. The transmission of Rocky Mountain spotted fever by the bite of the wood tick. J Am Med Asoc. 1906;47:358.CrossRefGoogle Scholar
  7. 7.
    Spencer RR, Parker RR. Rocky Mountain spotted fever: vaccination of monkeys and man. Pub Health Rep. 1925;40:2159–67.CrossRefGoogle Scholar
  8. 8.
    Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease- a tick-borne spirochetosis? Science. 1982;216:1317–9.PubMedCrossRefGoogle Scholar
  9. 9.
    CDC. Summary of notifiable infectious diseases and conditions – United States, 2015. CDC, MMWR. 2017;64(53):1–144.Google Scholar
  10. 10.
    Heymann DL, editor. Control of communicable diseases manual. 20th ed. Washington, DC: American Public Health Association; 2015.Google Scholar
  11. 11.
    Kirk JL, Fine DP, Sexton DJ, Muchmore HG. Rocky Mountain spotted fever: a clinical review based on 48 confirmed cases, 1943–1986. Medicine. 1990;69:35–45.PubMedCrossRefGoogle Scholar
  12. 12.
    CDC. Diagnosis and management of tickborne rickettsial diseases: Rocky Mounatin spotted fever, ehrlichioses, and anaplasmosis. MMWR. 2006;55(RR-4):1–29.Google Scholar
  13. 13.
    Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DEJ, Fritsche TR. Tick-borne diseases in the United States. N Engl J Med. 1993;329:936–47.PubMedCrossRefGoogle Scholar
  14. 14.
    Demma LJ, Traeger MS, Nicholson WL, Paddock CD, Blau DM, Eremeeva ME, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med. 2005;353(6):587–94.PubMedCrossRefGoogle Scholar
  15. 15.
    Goddard J, Layton MB. A Guide to Ticks of Mississippi. Mississippi Agriculture and Forestry Experiment Station, Mississippi State University, Bulletin Number 1150; 2006. 17 pp.Google Scholar
  16. 16.
    James AM, Freier JE, HKeirans JE, Durden LA, Mertins JW, Schlater JL. Distribution, seasonality, and hosts of the Rocky Mountain wood tick in the United States. J Med Entomol. 2006;43:17–24.PubMedCrossRefGoogle Scholar
  17. 17.
    Anonymous. Doxycycline for young children? Med Lett Drugs Ther. 2016;58:75.Google Scholar
  18. 18.
    Todd SR, Dahlgren FS, Traeger MS, Beltran-Aguilar ED, Marianos DW, Hamilton C, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015;166(5):1246–51.PubMedCrossRefGoogle Scholar
  19. 19.
    CDC. Consequences of delayed diagnosis of Rocky Mountain spotted fever in children – West Virginia, Michigan, Tennessee, and Oklahoma, May through July, 2000. CDC, MMWR. 2000;49:885–6.Google Scholar
  20. 20.
    Lackman DB, Parker RR, Gerloff RK. Serological characteristics of a pathogenic rickettsia occurring in Amblyomma maculatum. Public Health Rep. 1949;64:1342–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Parker RR. A pathogenic rickettsia from the Gulf Coast tick, Amblyomma maculatum. Proceedings of the third international congress on microbiology, New York;, 1940. p. 390–1.Google Scholar
  22. 22.
    Parker RR, Kohls GM, Cox GW, Davis GE. Observations on an infectious agent from Amblyomma maculatum. Public Health Rep. 1939;54:1482–4.CrossRefGoogle Scholar
  23. 23.
    Goddard J. Experimental infection of lone star ticks, Amblyomma americanum (L.), with Rickettsia parkeri and exposure of Guinea pigs to the agent. J Med Entomol. 2003;40:686–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Paddock CD, Sumner JW, Comer JA, Zaki SR, Goldsmith CS, Goddard J, et al. Rickettsia parkeri – a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis. 2004;38:805–11.PubMedCrossRefGoogle Scholar
  25. 25.
    Ekenna O, Paddock CD, Goddard J. Gulf Coast tick rash illness caused by Rickettsia parkeri. J Mississippi St Med Assoc. 2014;55:216–9.Google Scholar
  26. 26.
    Finley RW, Goddard J, Raoult D, Eremeeva ME, Cox RD, Paddock CD. Rickettsia parkeri: a case of tick-borne, eschar-associated spotted fever in Mississippi. International conference on emerging infectious diseases, Atlanta, GA, 2006 March 19–22, Abstract No 188; 2006.Google Scholar
  27. 27.
    Whitman TJ, Richards AL, Paddock CD, Tamminga CL, Sniezek PJ, Jiang J, et al. Rickettsia parkeri infection after tick bite, Virginia. Emerg Infect Dis. 2007;13:334–5.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Paddock CD, Goddard J. The evolving medical and veterinary importance of the Gulf Coast tick. J Med Entomol. 2015;52:230–52.PubMedCrossRefGoogle Scholar
  29. 29.
    Goddard J. American Boutonneuse Fever – a new spotted fever rickettsiosis. Inf Med. 2004;21:207–10.Google Scholar
  30. 30.
    Paddock CD, Allerdice ME, Karpathy SE, Nicholson WL, Levin ML, Smith TC, et al. Isolation and characterization of a unique strain of Rickettsia parkeri associated with the hard tick Dermacentor parumapertus Neumann in the western United States. Appl Environ Microbiol. 2017;17(10). https://doi.org/10.1128/AEM.03463-16.
  31. 31.
    Goddard J. A ten-year study of tick biting in Mississippi: implications for human disease transmission. J Agromedicine. 2002;8:25–32.PubMedCrossRefGoogle Scholar
  32. 32.
    Moraru GM, Goddard J, Murphy A, Link D, Belant JL, Varela-Stokes A. Evidence of antibodies to spotted fever group rickettsiae in small mammals and quail from Mississippi. Vector Borne Zoonotic Dis. 2013;13(1):1–5.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Bacellar F, Beati L, Franca A. Israeli spotted fever rickettsia associated with human disease in Portugal. Emerg Inf Dis. 1999;5:835–6.CrossRefGoogle Scholar
  34. 34.
    Raoult D, Fournier P, Abboud P, Caron F. First documented human Rickettsia aeschlimannii infection. Emerg Infect Dis. 2002;8:748–9.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Raoult D. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev. 1997;10:694–719.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Walker DH, Dumler JS. Emergence of the ehrlichioses as human health problems. Emerg Infect Dis. 1996;2:18–28.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE. Human infection with Ehrlichia canis a leukocytic rickettsia. N Engl J Med. 1987;316:853–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis. 1995;20:1102–10.PubMedCrossRefGoogle Scholar
  39. 39.
    Harris RM, Couturier BA, Sample SC, Coulter KS, Casey KK, Schlaberg R. Expanded geographic distribution and clinical characteristics of Ehrlichia ewingii infections, United States. Emerg Infect Dis. 2016;22(5):862.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Pritt BS, Sloan LM, Johnson DKH, Munderloh UG, Paskewitz SM, McElroy KM, et al. Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. New Engl J Med. 2011;365(5):422–9.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Wormser GP, Pritt B. Update and commentary on four emerging tick-borne infections: Ehrlichia muris-like agent, Borrelia miyamotoi, deer tick virus, Heartland virus, and whether ticks play a role in transmission of Bartonella henselae. Infect Dis Clin North Am. 2015;29(2):371–81.PubMedCrossRefGoogle Scholar
  42. 42.
    Dumler JS. Ehrlichiosis and anaplasmosis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens, and practice. 3rd ed. New York: Saunders Elsevier; 2011. p. 339–44.CrossRefGoogle Scholar
  43. 43.
    CDC. Anaplasmosis and ehrlichiosis – Maine, 2008. CDC, MMWR. 2009;58(37):1033–6.Google Scholar
  44. 44.
    Biggs H, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis – United States. CDC, MMWR, R&R. 2016;65:1–45.Google Scholar
  45. 45.
    Holman MS, Caporale DA, Goldberg J, Lacombe E, Lubelczyk C, Rand PW, et al. Anaplasma phagocytophilum, Babesia microti, and Borrelia burgdorferi in Ixodes scapularis in southern coastal Maine. Emerg Infect Dis. 2004;10:744–6.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Bope ET, Kellerman R. Conn’s current therapy. Philadelphia: Elsevier Saunders; 2017. 1375 pGoogle Scholar
  47. 47.
    Pritt BS, Respicio-Kingry LB, Sloan LM, Schriefer ME, Replogle AJ, Bjork J, et al. Borrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper midwestern United States. Int J Syst Evol Microbiol. 2016;66(11):4878–80.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Ginsberg HS, Faulde MK. Ticks. In: Bonnefoy X, Kampen H, Sweeney K, editors. Public health significance of urban pests. Copenhagen: WHO Regional Office for Europe; 2008. p. 303–45.Google Scholar
  49. 49.
    Kuehn BM. CDC estimates 300,000 U.S. cases of Lyme disease annually. JAMA. 2013;310:1110.PubMedCrossRefGoogle Scholar
  50. 50.
    Surveillance CDC. For Lyme disease – United States, 2008–2015. CDC, MMWR, Surveillance Summaries. 2017;66:1–13.Google Scholar
  51. 51.
    Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arth Rheum. 1977;20:7–17.CrossRefGoogle Scholar
  52. 52.
    Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, et al. The spirochetal etiology of Lyme disease. N Engl J Med. 1983;308:733–40.PubMedCrossRefGoogle Scholar
  53. 53.
    Spielman A, Clifford CM, Piesman J, Corwin MD. Human babesiosis on Nantucket island, USA: description of the vector, Ixodes dammini N.SP. J Med Entomol. 1979;15:218–34.PubMedCrossRefGoogle Scholar
  54. 54.
    Oliver JH, Owsley MR, Hutcheson HJ, James AM, Chunsheng C, Irby WS, et al. Conspecificity of the ticks Ixodes scapularis and Ixodes dammini. J Med Entomol. 1993;30:54–63.PubMedCrossRefGoogle Scholar
  55. 55.
    Keirans JE, Hutcheson HJ, Durden LA, Klompen JSH. Ixodes scapularis: redescription of all active stages, distribution, hosts, geographical distribution, and medical and veterinary importance. J Med Entomol. 1996;33:297–318.PubMedCrossRefGoogle Scholar
  56. 56.
    Goddard J. Not all erythema migrans lesions are Lyme disease. Am J Med. 2016.;epub ahead of print. https://doi.org/10.1016/j.amjmed:doi:10.1016/j.amjmed.
  57. 57.
    Nadelman RB. Tick-borne diseases: a focus on Lyme disease. Inf Med. 2006;23:267–80.Google Scholar
  58. 58.
    Rahn DW. Lyme disease – where’s the bug? N Engl J Med. 1994;330:282–3.PubMedCrossRefGoogle Scholar
  59. 59.
    Magnarelli LA. Current status of laboratory diagnosis for Lyme disease. Am J Med. 1995;98(suppl 4A):10s–4s.PubMedCrossRefGoogle Scholar
  60. 60.
    Goddard J, Piesman J. New records of immature Ixodes scapularis from Mississippi. J Vector Ecol. 2006;31(2):421.PubMedCrossRefGoogle Scholar
  61. 61.
    Masters EJ, Donnell HD, Fobbs M. Missouri Lyme disease: 1989 through 1992. J Spiro Tick-Borne Dis. 1994;1:12–3.Google Scholar
  62. 62.
    Goddard J, Varela-Stokes A, Finley RW. Lyme-disease-like illnesses in the South. J Mississippi State Med Assoc. 2012;53(3):68–72.Google Scholar
  63. 63.
    Farlow J, Wagner DM, Dukerich M, Stanley M, Chu M, Kubota K, et al. Francisella tularensis in the United States. Emerg Infect Dis. 2005;11:1835–41.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Olano JP, Peters CJ, Walker DH. Distinguishing tropical infectious diseases from bioterrorism. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens, and practice, vol. 2. Philadelphia: Churchill Livingstone; 2006. p. 1380–99.Google Scholar
  65. 65.
    Markowitz LE, Hynes NA, de la Cruz P, Campos E, Barbaree JM, Plikaytis BD, et al. Tick-borne tularemia. J Am Med Assoc. 1985;254:2922–5.CrossRefGoogle Scholar
  66. 66.
    Haake DA. Tularemia. In: Rakel RE, editor. Conn’s current therapy. Philadelphia: W.B. Saunders; 1997. p. 166–8.Google Scholar
  67. 67.
    Francis E, Mayne B. The occurrence of tularemia in nature as a disease of man. Public Health Rep. 1921;36:1731–8.CrossRefGoogle Scholar
  68. 68.
    Hopla CE. The ecology of tularemia. Adv Vet Sci Comp Med. 1974;18:25–53.PubMedGoogle Scholar
  69. 69.
    Parker RR, Spencer RR, Francis E. Tularemia infection in ticks of the species Dermacentor andersoni in the Bitteroot Valley, Montana. Public Health Rep. 1924;39:1052–73.CrossRefGoogle Scholar
  70. 70.
    Hopla CE. The transmission of tularemia organisms by ticks in the southern states. South Med J. 1960;53:92–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Cross JT. Tularemia in the United States. Inf Med. 1997;14:881–90.Google Scholar
  72. 72.
    Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis. 1994;19:42–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Homer M, Agular-Delfin I, Telford SRI, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev. 2000;13:451–69.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Telford SRI, Weller PF, Maquire JH. Babesiosis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens, and practice. 3rd ed. New York: Saunders Elsevier; 2011. p. 676–81.CrossRefGoogle Scholar
  75. 75.
    Gorenflot A, Moubri K, Precigout E, Carcy B, Schetters TP. Human babesiosis. Ann Trop Med Parasitol. 1998;92:489–501.PubMedCrossRefGoogle Scholar
  76. 76.
    CDC. Babesiosis – Connecticut. CDC, MMWR. 1989;38:649–50.Google Scholar
  77. 77.
    Markell E, Voge M, John D. Medical parasitology. 7th ed. Philadelphia: W.B. Saunders; 1992.Google Scholar
  78. 78.
    Spielman A, Wilson ML, Levine JF, Piesman JF. Ecology of Ixodes dammini-borne human babesiosis and Lyme disease. Annu Rev Entomol. 1985;30:439–60.PubMedCrossRefGoogle Scholar
  79. 79.
    Clark IA, Jacobson LS. Do babesiosis and malaria share a common disease process. Ann Trop Med Parasitol. 1998;92:483–8.PubMedCrossRefGoogle Scholar
  80. 80.
    Thomford JW, Conrad PA, Telford SR III, Mathiesen D, Eberhard ML, Herwaldt BL, et al. Cultivation and phylogenetic characterization of a newly recognized human pathogenic protozoan. J Infect Dis. 1994;169:1050–6.PubMedCrossRefGoogle Scholar
  81. 81.
    Hedayti T, Martin R. Babesiosis. e-medicince. http://www.emedicine.com/EMERG/topic49.htm; 2007.
  82. 82.
    Ternovoi VA, Protopopova EV, Chausov EV, Novikov DV, Leonova GN, Netesov SV, et al. Novel variant of tickborne encephalitis, Russia. Emerg Infect Dis. 2007;13:1574–8.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, et al. A new Phlebovirus associated with severe febrile illness in Missouri. N Engl J Med. 2012;367(9):834–41.PubMedCrossRefGoogle Scholar
  84. 84.
    Pastula DM, Turabelidze G, Yates KF, Jones TF, Lambert AJ, Panella AJ, et al. Heartland virus disease – United States, 2012–2013. CDC. MMWR. 2014;63:270–1.PubMedPubMedCentralGoogle Scholar
  85. 85.
    Kosoy OI, Lambert AJ, Hawkinson DJ, Pastula DM, Goldsmith CS, Hunt DC, et al. Novel thogotovirus associated with febrile illness and death, United States, 2014. Emerg Infect Dis. 2015;21(5):760–4.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Savage HM, Burkhalter KL, Godsey MSJ, Panella NA, Ashley DC, Nicholson WL, et al. Bourbon virus in field-collected ticks, Missouri, USA. Emerg Infect Dis. 2017;23(12):2017–22.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Monath TP, Johnson KM. Diseases transmitted primarily by arthropod vectors. In: Last JM, Wallace RB, editors. Public Health and Preventive Medicine. 13th ed. Norwalk: Appleton and Lange; 1992.Google Scholar
  88. 88.
    Gresikova M, Calisher CH. Tick-borne encephalitis. In: Monath TP, editor. The arboviruses: epidemiology and ecology, vol. 4. Boca Raton: CRC Press; 1989. p. 177–84.Google Scholar
  89. 89.
    Goddard J. Ticks and tick-borne diseases affecting military personnel. USAF, School of Aerospace Medicine: San Antonio; 1989. 140 pCrossRefGoogle Scholar
  90. 90.
    Gritsun TS, Lashkevich VA, Gould EA. Tick-borne encephalitis. Antivir Res. 2003;57:129–46.PubMedCrossRefGoogle Scholar
  91. 91.
    Hinten SR, Beckett GA, Gensheimer KF, Pritchard E, Courtney TM, Sears SD, et al. Increased recognition of Powassan encephalitis in the United States, 1999–2005. Vector-Borne Zoon Dis. 2008;8(6):733–40.CrossRefGoogle Scholar
  92. 92.
    Nuttall PA, Labuda M. Tick-borne encephalitis subgroup. In: Sonenshine DE, Mather TN, editors. Ecological dynamics of tick-borne zoonoses. New York: Oxford University Press; 1994. p. 351.Google Scholar
  93. 93.
    Telford SR III, Armstrong PM, Katavolos P, Foppa I, Garcia ASO, Wilson ML, et al. A new tick-borne encephalitis-like virus infecting New England deer ticks, Ixodes dammini. Emerg Infect Dis. 1997;3:165–70.PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Tavakoli NP, Wang H, Dupuis M, Hull R, Ebel GD, Gilmore EJ, et al. Fatal case of deer tick virus encephalitis. N Engl J Med. 2009;360(20):2099–107.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Aberle JH, Aberle SW, Kofler RM, Mandl CW. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis. J Virol. 2005;79:15107–13.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    WHO. Requirements for tick-borne encephalitis vaccine (inactivated). World Health Organization, Geneva, Technical Report Series, No. 889; 1999. p. 44–62.Google Scholar
  97. 97.
    Emmons R. Ecology of Colorado tick fever. Ann Rev Microbiol. 1988;42:49–64.CrossRefGoogle Scholar
  98. 98.
    Varma MGR. Ticks and mites. In: Lane RP, Crosskey RW, editors. Medical insects and arachnids. London: Chapman and Hall; 1993. p. chap. 18.Google Scholar
  99. 99.
    CDC. Tickborne relapsing fever – United States, 1990–2011. CDC, MMWR. 2015;64:58–60.Google Scholar
  100. 100.
    CDC. Outbreak of relapsing fever – Grand Canyon National Park, Arizona. CDC, MMWR. 1991;40:296–7.Google Scholar
  101. 101.
    Thompson RS, Burgdorfer W, Russell R, Francis BJ. Outbreak of tick-borne relapsing fever in Spokane County, Washington. J Am Med Assoc. 1969;210:1045–9.CrossRefGoogle Scholar
  102. 102.
    Trevejo RT, Schriefer ME, Gage KL, Safranek TJ, Orloski KA, Pape WJ, et al. An interstate outbreak of tick-borne relapsing fever among vacationers at a Rocky Mountain cabin. Am J Trop Med Hyg. 1998;58:743–7.PubMedCrossRefGoogle Scholar
  103. 103.
    CDC. Tickborne relapsing fever outbreak at an outdoor education Camp – Arizona, 2014. CDC, MMWR. 2015;64:651–2.Google Scholar
  104. 104.
    Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis. 1998;26:151–64.PubMedCrossRefGoogle Scholar
  105. 105.
    CDC. Common source outbreak of relapsing fever – California. CDC, MMWR. 1990;39:579.Google Scholar
  106. 106.
    Jongen VH, van Roosmalen J, Tiems J, Van Holten J, Wetsteyn JC. Tick-borne relapsing fever and pregnancy outcome in rural Tanzania. Acta Obstet Gynecol Scand. 1997;76:834–8.PubMedCrossRefGoogle Scholar
  107. 107.
    Edlow JA. Tick-borne diseases, relapsing fever. e-medicine, http://www.emedicine.com/EMERG/topic590.htm; 2007.
  108. 108.
    Kocan AA. Tick paralysis. J Am Vet Med Assoc. 1988;192:1498–500.PubMedGoogle Scholar
  109. 109.
    Gregson JD. Tick paralysis: an appraisal of natural and experimental data. Canada Dept. Agri. Monograph No. 9; 1973. p. 48.Google Scholar
  110. 110.
    Schmitt N, Bowmer EJ, Gregson JD. Tick paralysis in British Columbia. Canadian Med Assoc J. 1969;100:417–21.Google Scholar
  111. 111.
    Vedanarayanan VV, Evans OB, Subramony SH. Tick paralysis in children: electrophysiology and possibility of misdiagnosis. Neurology. 2002;59:1088–90.PubMedCrossRefGoogle Scholar
  112. 112.
    CDC. Cluster of tick paralysis cases – Colorado, 2006. CDC, MMWR. 2006;55:934–5.Google Scholar
  113. 113.
    Alexander JO. Arthropods and human skin. Berlin: Springer; 1984. 422 pCrossRefGoogle Scholar
  114. 114.
    Stanbury JB, Huyck JH. Tick paralysis: a critical review. Medicine. 1945;24:219–42.CrossRefGoogle Scholar
  115. 115.
    Gothe R, Kunze K, Hoogstraal H. The mechanisms of pathogenicity in the tick paralysis. J Med Entomol. 1979;16:357–69.PubMedCrossRefGoogle Scholar
  116. 116.
    Kaire GH. Isolation of tick paralysis toxin from Ixodes holocyclus. Toxicon. 1966;4:91–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Jerome Goddard
    • 1
  1. 1.Extension Professor of Medical EntomologyMississippi State UniversityMississippi StateUSA

Personalised recommendations